Quest Diagnostics Incorporated (NYSE:DGX) Jefferies 2025 Healthcare Services Conference September 29, 2025 4:35 PM EDT
Company Participants
Sam Samad – Executive VP & CFO
Conference Call Participants
Tycho Peterson – Jefferies LLC, Research Division
Presentation
Tycho Peterson
Jefferies LLC, Research Division
Okay, we’re going to kick it off. I’m Tycho Peterson from the life science team at Jefferies. It’s my pleasure to introduce our next company, Quest Diagnostic. We are pleased to have Sam and Shawn with us today.
Question-and-Answer Session
Tycho Peterson
Jefferies LLC, Research Division
Maybe to kick it off, I was able to sit in on some of the group meetings. And I think 1 of the things you’re talking a little bit about is some of the consumer initiations and applications. Maybe just talk a little bit about how you’re thinking about some of these new initiatives, including the WHOOP partnership?
Sam Samad
Executive VP & CFO
Yes. Sure, Tycho. And first of all, thanks for having us today and hosting us. The consumer health business that we have is something that we’re really excited about. It’s about a $250 — or $2.5 billion market. And a while back, we said we can get to 10% of this market in terms of adoption. So almost $250 million. And we’re well on our way to that. That business which is basically operated as a questhealth.com, where a patient can get on our website, order a test, get it fulfilled at a patient service center, get their blood drawn there and then get a result the next day. It’s a really convenient offering to patients and 1 that’s out of pocket, they pay for it directly.
So seeing great adoption in that business. But on top of that, I think, to your point about wearables, we’re also seeing now more interest
#Quest #Diagnostics #Incorporated #DGX #Presents #Jefferies #Healthcare #Services #Conference #Transcript